Baidu
map

2016 EDF/EADV循证指南:带状疱疹的管理

2016-08-31 欧洲皮肤病与性病学会 J Eur Acad Dermatol Venereol. 2016 Aug 31.

2016年8月,欧洲皮肤病学论坛(EDF)、欧洲皮肤病与性病学会(EADV)发布了带状疱疹的管理指南,本文主要为带状疱疹的治疗,内容包括治疗性干预评估,抗病毒药物的应用,疼痛管理,局部治疗等。 制定者: 欧洲皮肤病学论坛(EDF,European Dermatology Forum) 欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and

中文标题:

2016 EDF/EADV循证指南:带状疱疹的管理

英文标题:

European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.

发布日期:

2016-08-31

简要介绍:

2016年8月,欧洲皮肤病学论坛(EDF)、欧洲皮肤病与性病学会(EADV)发布了带状疱疹的管理指南,本文主要为带状疱疹的治疗,内容包括治疗性干预评估,抗病毒药物的应用,疼痛管理,局部治疗等。

制定者:

欧洲皮肤病学论坛(EDF,European Dermatology Forum)
欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and Venereology)

拓展指南:带状疱疹相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 EDF/EADV循证指南:带状疱疹的管理)] GetToolGuiderByIdResponse(projectId=1, id=df5ed1c001268859, title=2016 EDF/EADV循证指南:带状疱疹的管理, enTitle=European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment., guiderFrom=J Eur Acad Dermatol Venereol. 2016 Aug 31., authorId=null, author=, summary=2016年8月,欧洲皮肤病学论坛(EDF)、欧洲皮肤病与性病学会(EADV)发布了带状疱疹的管理指南,本文主要为带状疱疹的治疗,内容包括治疗性干预评估,抗病毒药物的应用,疼痛管理,局部治疗等。 制定者: 欧洲皮肤病学论坛(EDF,European Dermatology Forum) 欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and , cover=, journalId=null, articlesId=null, associationId=1016, associationName=欧洲皮肤病与性病学会, associationIntro=EADV is a non-profit association, founded in 1987, whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and Venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases., copyright=0, guiderPublishedTime=Wed Aug 31 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年8月,欧洲皮肤病学论坛(EDF)、欧洲皮肤病与性病学会(EADV)发布了带状疱疹的管理指南,本文主要为带状疱疹的治疗,内容包括治疗性干预评估,抗病毒药物的应用,疼痛管理,局部治疗等。<br> <br> <span style="font-weight: bold;">制定者:</span> <div>欧洲皮肤病学论坛(EDF,European Dermatology Forum)</div> <div>欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and Venereology)</div><div><br></div> 拓展指南:<strong>与<font color=red>带状疱疹</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=c54fc1c00126814a" title="2016 带状疱疹后神经痛诊疗中国专家共识" target=_blank>2016 带状疱疹后神经痛诊疗中国专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=9a5371c0011a147d" title="2014 CPS共识声明:带状疱疹疫苗预防带状疱疹后遗神经痛的安全性和有效性(更新版)" target=_blank>2014 CPS共识声明:带状疱疹疫苗预防带状疱疹后遗神经痛的安全性和有效性(更新版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=091f81c001032300" title="中国带状疱疹治疗指南(草稿)" target=_blank>中国带状疱疹治疗指南(草稿)</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E5%B8%A6%E7%8A%B6%E7%96%B1%E7%96%B9" target=_blank>有关带状疱疹更多指南</a></ul>, tagList=[TagDto(tagId=6986, tagName=带状疱疹)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7378, appHits=1233, showAppHits=0, pcHits=3947, showPcHits=3498, likes=118, shares=45, comments=3, approvalStatus=1, publishedTime=Fri Sep 02 16:34:17 CST 2016, publishedTimeString=2016-08-31, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Sep 02 16:34:17 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:42:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 EDF/EADV循证指南:带状疱疹的管理)])
2016 EDF/EADV循证指南:带状疱疹的管理
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1077936, encodeId=dcb510e793667, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e735571892, createdName=ms5000001084150499, createdTime=Wed Dec 08 05:22:39 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001601, encodeId=63761001601c5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210722/21d0d9acf2ba40a2bc8d432d25261f66/a11776949a9a489a8b7025f9aafd663f.jpg, createdBy=05815506710, createdName=ms3000001631836343, createdTime=Thu Jul 22 09:48:02 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-12-08 ms5000001084150499

    真不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1077936, encodeId=dcb510e793667, content=真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e735571892, createdName=ms5000001084150499, createdTime=Wed Dec 08 05:22:39 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001601, encodeId=63761001601c5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210722/21d0d9acf2ba40a2bc8d432d25261f66/a11776949a9a489a8b7025f9aafd663f.jpg, createdBy=05815506710, createdName=ms3000001631836343, createdTime=Thu Jul 22 09:48:02 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
    2021-07-22 ms3000001631836343

    不错

    0

Baidu
map
Baidu
map
Baidu
map